Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 18, 2005Colorectal Disease

Infliximab in the surgical management of complex fistulating anal Crohn's disease

View Full Paper
Ask AI
Bookmark
Share

Authors

CTCharlie TalbotPSP. M. SagarLeeds Teaching Hospitals NHS TrustMJMichael JohnstonAmgen (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Talbot et al. (2005) studied this question.

synapsesocial.com/papers/6aadef56d8a136f6c7b8aedfhttps://doi.org/10.1111/j.1463-1318.2004.00749.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1REGIONAL ILEITIS1932 · 1,515 citations
  2. 2A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease1997 · 3,167 citations
  3. 3ANAL PATHOLOGY IN PATIENTS WITH CROHN'S DISEASE1996 · 99 citations
  4. 4Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease2003 · 2,029 citations